TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11965102

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and radiotherapy for good responders
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and radiotherapy for good responders with fixed arytenoid
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and radiotherapy for good responders with non-fixed arytenoid
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arytenoid mobility before treatment
Number of subjects: 104
Study: 9475538

Group type: EXPERIMENTAL
Intervention: Retrograde autologous priming
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no retrograde autologous priming)
Number of subjects: 60
Study: 7707457

Group type: EXPERIMENTAL
Intervention: 12.5 mg/min erythromycin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2530609

Group type: EXPERIMENTAL
Intervention: Duovent (fenoterol with ipratropium bromide)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 17
Study: 7188826

Group type: EXPERIMENTAL
Intervention: Lactose-containing (LC) dairy drink (4.5% lactose)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Lactose-free (LF) dairy drink
Number of subjects: 110
Study: 30027819

Group type: EXPERIMENTAL
Intervention: Feasible gifts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Desirable gifts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Giver focused on practicality or ease of use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Giver focused on overall quality
Number of subjects: 0
Study: 28257412

Group type: EXPERIMENTAL
Intervention: Minimally invasive direct coronary artery bypass (MIDCAB)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Off-pump CABG (OP-CABG)
Number of subjects: 126
Study: 26941544

Group type: EXPERIMENTAL
Intervention: Laparoscopic procedure on the stomach (CPT code 43650)
Number of subjects: 4116

Group type: COMPARATOR
Intervention: Open gastrectomy (CPT code 43620‐2, 43631‐4)
Number of subjects: 4116
Study: 24825528

Group type: EXPERIMENTAL
Intervention: House Calls (HC)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Group Based (GB)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Individual Counseling (IC)
Number of subjects: 152
Study: 22275463

Group type: EXPERIMENTAL
Intervention: Virtual reality therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional arm therapy
Number of subjects: 18
Study: 20040895

Group type: EXPERIMENTAL
Intervention: 0.1 gxkg‐1 NaHCO3
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.2 gxkg‐1 NaHCO3
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.3 gxkg‐1 NaHCO3
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Single Morning Dosage (SMD) NaHCO3
Number of subjects: 8

Group type: COMPARATOR
Intervention: Single Evening Dosage (SED) NaHCO3
Number of subjects: 8

Group type: COMPARATOR
Intervention: Consecutive Evening Dosage (CED) NaHCO3
Number of subjects: 8
Study: 18549844

Group type: EXPERIMENTAL
Intervention: GM group (patients with geographic miss)
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: LGM group (longitudinal geographic miss)
Number of subjects: 1557

Group type: COMPARATOR
Intervention: no-GM group (patients without geographic miss)
Number of subjects: 1557

Group type: COMPARATOR
Intervention: no-LGM group (no longitudinal geographic miss)
Number of subjects: 1557
Study: 16022094

Group type: EXPERIMENTAL
Intervention: Cystic disease
Number of subjects: 1864

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 1864

Group type: EXPERIMENTAL
Intervention: Kt/V > or = 2.0
Number of subjects: 1864
Study: 11827923

Group type: COMPARATOR
Intervention: Balloon angioplasty (PTCA)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy followed by balloon angioplasty (ROTA)
Number of subjects: 298
Study: 10419079

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg daily
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Aspirin and Placebo (combined)
Number of subjects: 530
Study: 7579063

Group type: COMPARATOR
Intervention: Hemodialysis (HD)
Number of subjects: 702

Group type: COMPARATOR
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Healthy controls
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Comparison between HD and CAPD
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: HD and CAPD patients
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Patients with high-molecular-weight apolipoprotein(a) isoforms
Number of subjects: 702
Study: 2145347

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) infusion (0.1 microgram/kg/min during 30 minutes)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Salbutamol infusion (0.13 microgram/kg/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6109102

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 75
Study: 31101534

Group type: EXPERIMENTAL
Intervention: Docetaxel plus cisplatin and S-1
Number of subjects: 741

Group type: COMPARATOR
Intervention: Cisplatin and S-1
Number of subjects: 741
Study: 27761582

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg bolus followed by 75 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg daily (no bolus)
Number of subjects: 60
Study: 25867814

Group type: EXPERIMENTAL
Intervention: Exercise (90-minute treadmill walk at 50% maximal oxygen uptake)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 10
Study: 24169063

Group type: EXPERIMENTAL
Intervention: Ciclesonide hydrofluoroalkane nasal aerosol (CIC‐HFA) at 74 micrograms
Number of subjects: 294

Group type: COMPARATOR
Intervention: Mometasone furoate aqueous nasal spray (MFNS) at 200 micrograms
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Ciclesonide hydrofluoroalkane nasal aerosol (CIC‐HFA)
Number of subjects: 294
Study: 21251625

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 619
Study: 19517198

Group type: EXPERIMENTAL
Intervention: Closed lateral sphincterotomy (LS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nitroglycerine ointment (GTN)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Injection of botulinum toxin (BTX)
Number of subjects: 63
Study: 18007569

Group type: EXPERIMENTAL
Intervention: Oral ziprasidone (20 mg) after an 8-hour fast
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral ziprasidone (40 mg) after an 8-hour fast
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral ziprasidone (80 mg) after an 8-hour fast
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral ziprasidone (40 mg) with a high-fat meal (60% fat)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oral ziprasidone (40 mg) with a moderate-fat meal (30% fat)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oral ziprasidone (40 mg) under fasting conditions
Number of subjects: 22
Study: 14718823

Group type: EXPERIMENTAL
Intervention: TriVex (powered phlebectomy)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Conventional varicose vein surgery
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: TriVex
Number of subjects: 141
Study: 11292231

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9041947

Group type: EXPERIMENTAL
Intervention: L-arginine (8 gm/day for 28 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7933370

Group type: EXPERIMENTAL
Intervention: Intervention group (home visits and center-based schooling)
Number of subjects: 985

Group type: COMPARATOR
Intervention: Follow-up only group
Number of subjects: 985
Study: 3216031

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg controlled-release tablet every 8 hours with cimetidine 300 mg four times a day for 7 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pentoxifylline 400 mg controlled-release tablet every 8 hours without cimetidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg controlled-release tablet every 8 hours with cimetidine
Number of subjects: 10
Study: 31931853

Group type: EXPERIMENTAL
Intervention: Guhong injection
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 29040947

Group type: EXPERIMENTAL
Intervention: quetiapine XR
Number of subjects: 388

Group type: COMPARATOR
Intervention: chlorpromazine
Number of subjects: 388
Study: 28874596

Group type: EXPERIMENTAL
Intervention: Panax ginseng extract (PG) 400 mg twice daily for 28 days
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Panax ginseng extract (PG)
Number of subjects: 127
Study: 26230399

Group type: EXPERIMENTAL
Intervention: 3 mm lateral wedge insole
Number of subjects: 36

Group type: COMPARATOR
Intervention: 6 mm medial wedge insole
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: KAAI increase or decrease groups
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Absolute % change in KAAI
Number of subjects: 36
Study: 24565129

Group type: EXPERIMENTAL
Intervention: Intravenous morphine (Group IVM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural morphine (Group EM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural morphine-bupivacaine (Group EMB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epidural morphine-ropivacaine (Group EMR)
Number of subjects: 60
Study: 20478681

Group type: COMPARATOR
Intervention: Walking Advice (WA)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Supervised Exercise Therapy (SET)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: SET with Feedback
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: SET
Number of subjects: 304
Study: 18443313

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 40 mg IV
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline) IV
Number of subjects: 10
Study: 16061499

Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 1518

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1518
Study: 11914314

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10344353

Group type: EXPERIMENTAL
Intervention: Theophylline (810 mg daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9180981

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (RL, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch 6% (HEA, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Normal saline (NaCl, n = 10)
Number of subjects: 30
Study: 1919149

Group type: EXPERIMENTAL
Intervention: Cimetidine, 50 mg/kg administered intravenously immediately before IPHP
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no cimetidine)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control
Number of subjects: 18
Study: 6818581

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31809215

Group type: EXPERIMENTAL
Intervention: CEUS
Number of subjects: 112

Group type: COMPARATOR
Intervention: CECT
Number of subjects: 112

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 112
Study: 29880243

Group type: EXPERIMENTAL
Intervention: Tdap administered 3-4 weeks before MCV4 and PCV13
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Tdap administered concomitantly with MCV4 and PCV13
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: MCV4 and PCV13 administered 3-4 weeks before Tdap
Number of subjects: 166
Study: 27498916

Group type: EXPERIMENTAL
Intervention: Budesonide (by face mask inhalation or aerosol inhaler)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fluticasone (by inhaler)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline inhalation (control)
Number of subjects: 60
Study: 24285251

Group type: EXPERIMENTAL
Intervention: SMOFlipid 20%
Number of subjects: 40

Group type: COMPARATOR
Intervention: MCT/LCT (Lipovenoes 20%)
Number of subjects: 40
Study: 22258622

Group type: EXPERIMENTAL
Intervention: Classification-based treatment
Number of subjects: 156

Group type: COMPARATOR
Intervention: Usual physical therapy care
Number of subjects: 156
Study: 19175871

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV)
Number of subjects: 924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 924
Study: 16846547

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (MPFF), six tablets per day for 4 days followed by four tablets per day for 3 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 12744364

Group type: EXPERIMENTAL
Intervention: Intravenous vancomycin (2 g/day, four infusions/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intraventricular vancomycin (10 mg once daily)
Number of subjects: 10
Study: 11168190

Group type: EXPERIMENTAL
Intervention: Immediate loading of implants (EG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard 2-stage protocol (CG)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups (EG and CG)
Number of subjects: 22
Study: 8997652

Group type: EXPERIMENTAL
Intervention: Salifluor combined with PVM/MA copolymer and NaF in mouthrinse and dentifrice formulations.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non fluoride dentifrice containing salifluor and PVM/MA copolymer with dicalcium phosphate dihydrate abrasive.
Number of subjects: 0
Study: 1443440

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation for 6 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo treatment for 6 weeks
Number of subjects: 49
Study: 6728584

Group type: EXPERIMENTAL
Intervention: Pediatric Home Care (PHC) program
Number of subjects: 219
Study: 30266581

Group type: EXPERIMENTAL
Intervention: Oleic acid (OA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Olive oil (OO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Older men
Number of subjects: 20

Group type: COMPARATOR
Intervention: Middle-aged men
Number of subjects: 20
Study: 29562659

Group type: EXPERIMENTAL
Intervention: Three energy drinks (EDs) consumed at one-hour intervals (240 mg of caffeine total)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 68
Study: 27087449

Group type: EXPERIMENTAL
Intervention: SEED 1dayPure moisture contact lenses with alginic acid (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: SEED 1dayPure moisture contact lenses without alginic acid (n = 15)
Number of subjects: 30
Study: 25304296

Group type: EXPERIMENTAL
Intervention: Palaeolithic-type diet
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy reference diet
Number of subjects: 34
Study: 22405352

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg and pioglitazone 30 mg (base study)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg and pioglitazone 45 mg (extension study)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Pioglitazone monotherapy (30 mg)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Pioglitazone monotherapy (45 mg)
Number of subjects: 520
Study: 21337796

Group type: EXPERIMENTAL
Intervention: Therapeutic Touch
Number of subjects: 30
Study: 19227591

Group type: EXPERIMENTAL
Intervention: Use of a validated prognostic score for mortality risk
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (questionnaire only)
Number of subjects: 68
Study: 15664241

Group type: EXPERIMENTAL
Intervention: Lamivudine 100mg/day
Number of subjects: 76
Study: 12017407

Group type: EXPERIMENTAL
Intervention: Insulin lispro (insulin LP)
Number of subjects: 481

Group type: COMPARATOR
Intervention: Insulin R
Number of subjects: 481
Study: 10394005

Group type: EXPERIMENTAL
Intervention: First-line treatment with monotherapy on an outpatient basis
Number of subjects: 0
Study: 7580637

Group type: EXPERIMENTAL
Intervention: Intensive diabetic therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional diabetic therapy
Number of subjects: 70
Study: 2290653

Group type: EXPERIMENTAL
Intervention: Cavit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T.E.R.M.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 6766731

Group type: EXPERIMENTAL
Intervention: acebutolol 200 mg twice daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: acebutolol 400 mg once daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: acebutolol (both dosages)
Number of subjects: 13

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study: 31099869

Group type: EXPERIMENTAL
Intervention: Deep learning model (CNN)
Number of subjects: 3082

Group type: EXPERIMENTAL
Intervention: Deep learning model (CNN) applied to colonoscopy videos
Number of subjects: 3082

Group type: COMPARATOR
Intervention: Experienced human reviewers
Number of subjects: 3082
Study: 27647784

Group type: EXPERIMENTAL
Intervention: Haemodynamic-guided heart failure management (Treatment group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (Control group)
Number of subjects: 0
Study: 26281946

Group type: EXPERIMENTAL
Intervention: Physical therapy (manual therapies including desensitization maneuvers), n = 60
Number of subjects: 120

Group type: COMPARATOR
Intervention: Surgery (decompression/release of the carpal tunnel), n = 60
Number of subjects: 120
Study: 24293754

Group type: EXPERIMENTAL
Intervention: Home respiratory polygraphy (HRP)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Elective HRP
Number of subjects: 366

Group type: COMPARATOR
Intervention: Home respiratory polygraphy (HRP) for all patients
Number of subjects: 366

Group type: COMPARATOR
Intervention: Home respiratory polygraphy (HRP) for symptomatic patients and PSG for the rest
Number of subjects: 366
Study: 20977487

Group type: EXPERIMENTAL
Intervention: Newer pamphlet providing descriptions of common causes of anemia and advice for seeking medical attention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Older pamphlet providing a list of iron‐rich foods
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Blood center practices for care of donors with low Hct
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Study of donors with low Hct
Number of subjects: 104
Study: 20035395

Group type: EXPERIMENTAL
Intervention: Non-DEHP bilayer group (group B)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Noncoated PVC group (group N)
Number of subjects: 16
Study: 17122108

Group type: EXPERIMENTAL
Intervention: Lutein supplementation (10 mg/d for 6 months)
Number of subjects: 45
Study: 14506371

Group type: EXPERIMENTAL
Intervention: Measles vaccine
Number of subjects: 433

Group type: COMPARATOR
Intervention: Inactivated polio vaccine
Number of subjects: 433
Study: 11060137

Group type: EXPERIMENTAL
Intervention: 8 % CHO beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHO ingestion
Number of subjects: 0
Study: 9382020

Group type: EXPERIMENTAL
Intervention: Antimyosin imaging
Number of subjects: 7
Study: 8285950

Group type: EXPERIMENTAL
Intervention: propofol in combination with ketamine 20 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: propofol in combination with fentanyl 0.1 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: thiopentone in combination with fentanyl 0.1 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: methohexitone in combination with fentanyl 0.1 mg
Number of subjects: 200
Study: 3929874

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 183
Study: 30303626

Group type: EXPERIMENTAL
Intervention: Nemiralisib (200, 500, and 700 μg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nemiralisib
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29126244

Group type: EXPERIMENTAL
Intervention: nCRT (carboplatin/paclitaxel with 41.4-Gy radiotherapy) plus surgery
Number of subjects: 368

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: nCRT plus surgery
Number of subjects: 368
Study: 27025777

Group type: EXPERIMENTAL
Intervention: Subcutaneous drainage (DG)
Number of subjects: 62

Group type: COMPARATOR
Intervention: No drainage group (NDG)
Number of subjects: 62
Study: 25191771

Group type: EXPERIMENTAL
Intervention: Rivastigmine treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Healthy controls (no treatment)
Number of subjects: 18
Study: 22079178

Group type: EXPERIMENTAL
Intervention: Dietary intervention for weight loss maintenance
Number of subjects: 932
Study: 19268926

Group type: EXPERIMENTAL
Intervention: Assisted hatching performed by acidic Tyrode's solution
Number of subjects: 121

Group type: COMPARATOR
Intervention: No procedure (unhatched)
Number of subjects: 121
Study: 17301956

Group type: EXPERIMENTAL
Intervention: Intravenous carboplatin (18.7 mg/kg for patients < 12 kg, 560 mg/m(2) for patients >/= 12 kg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Intravenous carboplatin
Number of subjects: 25
Study: 16204601

Group type: EXPERIMENTAL
Intervention: Heated humidification
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (no heated humidification)
Number of subjects: 70
Study: 12365851

Group type: EXPERIMENTAL
Intervention: Active responding in matched condition
Number of subjects: 4

Group type: COMPARATOR
Intervention: Non-matched condition
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Passive tasks
Number of subjects: 4

Group type: COMPARATOR
Intervention: Active tasks
Number of subjects: 4
Study: 12451320

Group type: EXPERIMENTAL
Intervention: Candesartan (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 20
Study: 9732929

Group type: EXPERIMENTAL
Intervention: Sodium picosulphate plus magnesium citrate (SPS‐Mg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sulphate-free polyethylene glycol electrolyte lavage (PEG‐EL)
Number of subjects: 68
Study: 8060692

Group type: EXPERIMENTAL
Intervention: Molloplast-b (silicone-based)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Palasiv 62 (heat-cured plasticised acrylic)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both materials
Number of subjects: 44